Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
48.5M
-
Shares change
-
+2.1M
-
Total reported value, excl. options
-
$1.08B
-
Value change
-
+$47.1M
-
Put/Call ratio
-
0.71
-
Number of buys
-
67
-
Number of sells
-
-64
-
Price
-
$22.36
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q1 2021
161 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q1 2021.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.5M shares
of 86.6M outstanding shares and own 56.01% of the company stock.
Largest 10 shareholders include Avidity Partners Management LP (3.85M shares), WELLINGTON MANAGEMENT GROUP LLP (2.97M shares), BlackRock Inc. (2.68M shares), STATE STREET CORP (2.65M shares), Avoro Capital Advisors LLC (2.5M shares), BOXER CAPITAL, LLC (2.29M shares), CITADEL ADVISORS LLC (2.23M shares), VANGUARD GROUP INC (2.07M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.02M shares), and Nantahala Capital Management, LLC (2M shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.